← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Recursion Pharmaceuticals, Llc
Salt Lake City, UT
$3,515,236
Total funding
4
Grants
Funding over time
peak $1.3M · FY2015–20$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,515,236 · 4
By mechanism
R44$3,073,259 · 2
R43$441,977 · 2
Investigators at Recursion Pharmaceuticals, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Expansion of an efficient drug repurposing platform for rare genetic diseases.$809,130
R44 · FY2015 · TR
Expansion of an efficient drug repurposing platform for rare genetic diseases.$650,041
R44 · FY2016 · TR
Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction$509,173
R44 · FY2018 · AG
Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction$447,905
R44 · FY2020 · AG
Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction$434,004
R44 · FY2019 · AG
Application of an efficient drug repurposing platform to identify treatments for Cornelia De Lange Syndrome$224,625
R43 · FY2015 · HD
Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction$223,006
R44 · FY2016 · AG
HLS13-04 High-Content High-Throughput Screen for Diamond Blackfan Anemia Treatments$217,352
R43 · FY2015 · HL